284 related articles for article (PubMed ID: 26138244)
1. Hepatocellular nodules resulting from congenital extrahepatic portosystemic shunts can differentiate into potentially malignant hepatocellular adenomas.
Sanada Y; Mizuta K; Niki T; Tashiro M; Hirata Y; Okada N; Yamada N; Ihara Y; Urahashi T; Soejima Y; Fukusato T; Kondo F
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):746-56. PubMed ID: 26138244
[TBL] [Abstract][Full Text] [Related]
2. Re: Hepatocellular nodules resulting from congenital extrahepatic portosystemic shunts can differentiate into potentially malignant hepatocellular adenomas.
Guérin F; Franchi-Abella S
J Hepatobiliary Pancreat Sci; 2015 Dec; 22(12):E51. PubMed ID: 26768670
[No Abstract] [Full Text] [Related]
3. Response to Re: Hepatocellular nodules resulting from congenital extrahepatic portosystemic shunts can differentiate into potentially malignant hepatocellular adenomas.
Sanada Y; Mizuta K; Kondo F
J Hepatobiliary Pancreat Sci; 2015 Dec; 22(12):E52-3. PubMed ID: 26768671
[No Abstract] [Full Text] [Related]
4. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
[TBL] [Abstract][Full Text] [Related]
5. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.
Balabaud C; Laurent C; Le Bail B; Castain C; Possenti L; Frulio N; Chiche L; Blanc JF; Bioulac-Sage P
Liver Int; 2018 Jul; 38(7):1273-1279. PubMed ID: 29265678
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
7. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Hepatic Adenoma in a Child With a Congenital Extrahepatic Portosystemic Shunt.
Glonnegger H; Schulze M; Kathemann S; Berg S; Füllgraf H; Tannapfel A; Gerner P; Grohmann J; Niemeyer C; Hettmer S
Front Pediatr; 2020; 8():501. PubMed ID: 32984213
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
[TBL] [Abstract][Full Text] [Related]
11. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
12. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract][Full Text] [Related]
13. [Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Ann Pathol; 2010 Dec; 30(6):439-47. PubMed ID: 21167430
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.
Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C
Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.
Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G
Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.
Shih A; Lauwers GY; Balabaud C; Bioulac-Sage P; Misdraji J
Am J Surg Pathol; 2015 Sep; 39(9):1296-300. PubMed ID: 26274031
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.
Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P
J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
Agarwal S; Fuentes-Orrego JM; Arnason T; Misdraji J; Jhaveri KS; Harisinghani M; Hahn PF
AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
[TBL] [Abstract][Full Text] [Related]
20. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification.
Balabaud C; Al-Rabih WR; Chen PJ; Evason K; Ferrell L; Hernandez-Prera JC; Huang SF; Longerich T; Park YN; Quaglia A; Schirmacher P; Sempoux C; Thung SN; Torbenson M; Wee A; Yeh MM; Yeh SH; Le Bail B; Zucman-Rossi J; Bioulac-Sage P
Int J Hepatol; 2013; 2013():268625. PubMed ID: 23691331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]